Silicosis secondary prevention: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Silicosis}}
{{Silicosis}}
{{CMG}} {{AE}}
{{CMG}} {{AE}} {{AV}}
 
==Overview==
==Overview==
Following diagnosis, secondary prevention is the main approach for the management of patients with silicosis. Secondary prevention measures include avoidance of continued exposure, [[smoking cessation]], routine medical surveillance, and administration of [[influenza]] and [[pneumococcal vaccine|pneumococcal vaccines]].<ref name="pmid22534002">{{cite journal| author=Leung CC, Yu IT, Chen W| title=Silicosis. | journal=Lancet | year= 2012 | volume= 379 | issue= 9830 | pages= 2008-18 | pmid=22534002 | doi=10.1016/S0140-6736(12)60235-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22534002  }} </ref>
Following diagnosis, secondary prevention is the main approach for the management of patients with silicosis. Secondary prevention measures include avoidance of continued exposure, [[smoking cessation]], routine medical surveillance, and administration of [[influenza]] and [[pneumococcal vaccine|pneumococcal vaccines]].<ref name="pmid22534002">{{cite journal| author=Leung CC, Yu IT, Chen W| title=Silicosis. | journal=Lancet | year= 2012 | volume= 379 | issue= 9830 | pages= 2008-18 | pmid=22534002 | doi=10.1016/S0140-6736(12)60235-9 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22534002  }} </ref>
Line 18: Line 19:
===Vaccine Administration===
===Vaccine Administration===
*Patients diagnosed with silicosis should be advised to receive both the [[influenza]] and the [[pneumonoccal vaccine]].
*Patients diagnosed with silicosis should be advised to receive both the [[influenza]] and the [[pneumonoccal vaccine]].
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Occupational diseases]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Latest revision as of 15:38, 8 June 2016

Silicosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Silicosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Silicosis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Silicosis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Silicosis secondary prevention

CDC on Silicosis secondary prevention

Silicosis secondary prevention in the news

Blogs on Silicosis secondary prevention

Directions to Hospitals Treating Silicosis

Risk calculators and risk factors for Silicosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

Following diagnosis, secondary prevention is the main approach for the management of patients with silicosis. Secondary prevention measures include avoidance of continued exposure, smoking cessation, routine medical surveillance, and administration of influenza and pneumococcal vaccines.[1]

Secondary Prevention

Avoidance of Continued Exposure

  • Avoidance of continued exposure to environments with high concentrations of silica is recommended.

Smoking Cessation

Routine Medical Surveillance

Vaccine Administration

References

  1. Leung CC, Yu IT, Chen W (2012). "Silicosis". Lancet. 379 (9830): 2008–18. doi:10.1016/S0140-6736(12)60235-9. PMID 22534002.

Template:WH Template:WS